NPI: 1699102715 · MIAMI GARDENS, FL 33169 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/03/2013
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/03/2013 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,349 | $914K |
| 2019 | 21,304 | $2.95M |
| 2020 | 19,859 | $3.06M |
| 2021 | 14,737 | $1.55M |
| 2022 | 12,998 | $2.91M |
| 2023 | 1,174 | $283K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 25,838 | 1,076 | $4.11M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 21,089 | 1,398 | $3.16M |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,355 | 908 | $1.80M |
| J1756 | Injection, iron sucrose, 1 mg | 5,165 | 893 | $704K |
| A4657 | Syringe, with or without needle, each | 2,408 | 1,117 | $476K |
| 82728 | 1,427 | 927 | $214K | |
| 83540 | 1,486 | 964 | $213K | |
| 83550 | 1,486 | 964 | $213K | |
| 85041 | 1,387 | 931 | $206K | |
| 85048 | 1,383 | 928 | $205K | |
| 83970 | 1,216 | 732 | $186K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 741 | 353 | $105K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 146 | 97 | $25K |
| 82746 | 94 | 60 | $17K | |
| 82108 | 88 | 57 | $17K | |
| 82607 | 92 | 58 | $17K | |
| G0008 | Administration of influenza virus vaccine | 20 | 16 | $2K |